Innova IVF

Infertility affects 1 in 6 couples globally, especially those over the age of 35. In vitro fertilisation (IVF) offers a potential solution, with embryo selection being a critical step in the process.

Current market solutions have a success rate of only 20% to 30%, often requiring couples to undergo multiple cycles to achieve a clinical pregnancy. This not only incurs significant costs but also subjects couples to the emotional and physical toll of repeated miscarriages.

At InnovaIVF, we are developing a cutting-edge medical device that evaluates embryo viability through a novel biological marker: metabolic activity. This innovation aims to enhance the accuracy of embryo selection, providing more cost-effective treatments and a better overall experience for both patients and healthcare providers.